How to Hedging the Market in March and April

"The bullish theses in March and April were really dumb. Really, really dumb," he says. "It made no sense to have any shorts on at the bottom there." He should have gone 50-50 cash or something like that rather than shorting shares of biotech companies such as Gilead Sciences (GILD)